Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Basil extract is a botanical substance derived from various species of the *Ocimum* genus, most notably *Ocimum basilicum* (sweet basil) and *Ocimum sanctum* (holy basil or tulsi). The extract is rich in bioactive polyphenols, including rosmarinic acid, luteolin, and various flavonoids, which confer antioxidant, anti-inflammatory, and antimicrobial properties. In clinical research, basil extract is being evaluated for its ability to reduce gastric mucosal inflammation in functional dyspepsia and to manage recurrent aphthous stomatitis through topical application. Preclinical studies also suggest potential therapeutic roles in managing hyperglycemia, hyperlipidemia, and bacterial pneumonia by modulating pro-inflammatory cytokines and oxidative stress pathways. Beyond its medicinal applications, it is utilized as a natural preservative in food systems and as an immunostimulant in aquaculture.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on basil extract.